Co-morbidity of Kawasaki Disease

被引:0
|
作者
Fang-Liang Huang
Te-Kau Chang
Sheng-Ling Jan
Chi-Ren Tsai
Li-Chung Wang
Mei-Chin Lai
Po-Yen Chen
机构
[1] Taichung Veterans General Hospital,Department of Pediatrics
[2] National Chung Hsing University,Department of Pathology and Laboratory Medicine
[3] Hungkuang University,undefined
[4] Taichung Veterans General Hospital,undefined
来源
关键词
Kawasaki disease; Epstein-Barr virus; Autoimmune hemolytic anemia;
D O I
暂无
中图分类号
学科分类号
摘要
Despite more than four decades of investigation, the etiology of Kawasaki disease remains obscure, and none of the proposed etiologic theories for the disease have achieved independent confirmation. Clinical and epidemiologic features support an infectious cause, but the etiology remains unclear. The authors present a case of Kawasaki disease associated with Epstein-Barr virus and Mycoplasma pneumoniae infection in a 3.5-y-old boy. He received two doses of intravenous immunoglobulin due to prolonged course of Kawasaki disease but later had complicated autoimmune haemolytic anaemia. His prolonged fever subsided after azithromycin administration. Epstein-Barr virus infection was confirmed by molecular microbiological pathology of cervical lymph node and serological tests. The serological tests for Mycoplasma pneumoniae also revealed a positive result. Thus, it is concluded that Mycoplasma pneumoniae and Epstein-Barr virus infections may occur simultaneously in a child with Kawasaki disease. In addition, autoimmune hemolytic anaemia may be noted in Kawasaki disease patients after high-dose IVIG administration. To the authors’ knowledge, this is the first report of Kawasaki disease with Epstein-Barr virus and Mycoplasma pneumoniae in the English-language literature.
引用
收藏
页码:815 / 817
页数:2
相关论文
共 50 条
  • [1] Co-morbidity of Kawasaki Disease
    Huang, Fang-Liang
    Chang, Te-Kau
    Jan, Sheng-Ling
    Tsai, Chi-Ren
    Wang, Li-Chung
    Lai, Mei-Chin
    Chen, Po-Yen
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2012, 79 (06): : 815 - 817
  • [2] CO-MORBIDITY BETWEEN DEPRESSION AND CARDIOVASCULAR DISEASE
    Halaris, A.
    [J]. PSYCHIATRY AND THE NEUROSCIENCES: INTERNATIONAL PERSPECTIVES, 2011, : 163 - 169
  • [3] THE IMPACT OF CO-MORBIDITY ON THE DISEASE BURDEN OF VTE
    Kroep, S.
    Chuang, L.
    van Hout, B.
    Agnelli, G.
    Gumbs, P. D.
    Gitt, A. K.
    Monreal, M.
    Bauersachs, R.
    Mismetti, P. S.
    Willich, S. W.
    Cohen, A. T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A601 - A601
  • [4] The impact of co-morbidity on the disease burden of VTE
    Sonja Kroep
    Ling-Hsiang Chuang
    Alexander Cohen
    Pearl Gumbs
    Ben van Hout
    Manuel Monreal
    Stefan N. Willich
    Anselm Gitt
    Rupert Bauersachs
    Giancarlo Agnelli
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 507 - 515
  • [5] The impact of co-morbidity on the disease burden of VTE
    Kroep, Sonja
    Chuang, Ling-Hsiang
    Cohen, Alexander
    Gumbs, Pearl
    van Hout, Ben
    Monreal, Manuel
    Willich, Stefan N.
    Gitt, Anselm
    Bauersachs, Rupert
    Agnelli, Giancarlo
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 507 - 515
  • [6] Co-morbidity and Mortality in Alzheimer's Disease
    Schoepf, D.
    Heun, R.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [7] Addiction and Co-Morbidity
    Reimer, J.
    [J]. SUCHTTHERAPIE, 2014, 15 (01) : 8 - 8
  • [8] Cardiovascular Co-Morbidity
    不详
    [J]. UNFALLCHIRURG, 2011, 114 (08): : 653 - 653
  • [9] Co-Morbidity and Rehabilitation
    van der Poel, L.
    O'Kelly, J.
    Dolan, E.
    McCormack, P. M. E.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S271 - S272
  • [10] Addiction and co-morbidity
    Scheibenbogen, Oliver
    Feselmayer, Senta
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (3-4) : 807 - 807